Neurocrine Biosciences | 流动负债

Current Liabilities 更改 日
AbbVie USD 41.52B 6.75B 2024-03
Acadia Pharmaceuticals USD 330.6M 76.34M 2024-03
Agios Pharmaceuticals USD 51.69M 16.26M 2024-03
ALKERMES USD 458.98M 56.7M 2024-03
Alnylam Pharmaceuticals USD 941.71M 26.08M 2024-03
Amgen USD 19.71B 1.32B 2024-03
Biogen USD 3.22B 211.5M 2024-03
BioMarin Pharmaceutical USD 1.09B 89.12M 2024-03
Cytokinetics USD 88.85M 13.82M 2024-03
Dynavax Technologies USD 56M 6.19M 2024-03
Exelixis USD 373.01M 3.81M 2024-03
Gilead Sciences USD 13.02B 1.74B 2024-03
Halozyme Therapeutics USD 131.64M 19.14M 2024-03
Incyte USD 1.4B 156.07M 2024-03
Intra Cellular Therapies USD 134.8M 11.26M 2024-03
Ionis Pharmaceuticals USD 327.65M 120.44M 2024-03
Neurocrine Biosciences USD 712.9M 21.3M 2024-03
Pfizer USD 40.5B 9.36B 2024-03
Prothena USD 43.27M 13.62M 2024-03
Regeneron Pharmaceuticals USD 3.58B 823.3M 2024-03
Repligen USD 178.32M 185.05M 2024-03
Sarepta Therapeutics USD 608.71M 157.97M 2024-03
Teva Pharmaceutical Industries USD 13.79B 1.55B 2024-03
Ultragenyx Pharmaceutical USD 245.58M 8.4M 2024-03
Vertex Pharmaceuticals USD 3.8B 196.5M 2024-03



Neurocrine Biosciences 流动负债 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.